RxSight (RXST) EV to EBITDA (2021 - 2023)
RxSight's (RXST) EV to EBITDA was 201.90 for Q2 2023, compared with 2.28 a year earlier.
Powered by 
Analysis
RxSight (RXST) EV to EBITDA (2021 - 2023) Analysis & Trends
For FY2021, EV to EBITDA at RxSight was -0.11.
- Per Business Quant data, the three quarters before Q2 2023 came in at 12.23 (Q1 2023), 6.77 (Q4 2022) and 1.53 (Q3 2022).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 251.30 Bn | 230.45 Bn | 4.88 Bn |
| 2 | Abbott Laboratories | 174.70 Bn | 145.78 Bn | 7.27 Bn |
| 3 | Danaher | 158.94 Bn | 142.76 Bn | 3.61 Bn |
| 4 | Intuitive Surgical | 145.87 Bn | 125.42 Bn | 1.96 Bn |
| 5 | Medtronic | 111.49 Bn | 77.36 Bn | 6.34 Bn |
| 6 | Stryker | 106.96 Bn | 93.08 Bn | 4.50 Bn |
| 7 | Boston Scientific | 63.62 Bn | 58.63 Bn | 3.85 Bn |
| 8 | Edwards Lifesciences | 50.80 Bn | 34.92 Bn | 1.35 Bn |
| 9 | Becton Dickinson | 49.59 Bn | 46.74 Bn | 2.32 Bn |
| 10 | RxSight | 198.36 Mn | -10.44 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2023 | 201.90 |
| Mar 31, 2023 | 12.23 |
| Dec 31, 2022 | 6.77 |
| Sep 30, 2022 | 1.53 |
| Jun 30, 2022 | 2.28 |
| Mar 31, 2022 | 1.75 |
| Dec 31, 2021 | -0.07 |
API Access
RxSight EV to EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ev-to-ebitda&ticker=RXST&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ev-to-ebitda", "ticker": "RXST", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ev-to-ebitda&ticker=RXST&period=max&api_key=YOUR_API_KEY");
const data = await res.json();